Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.049 | A prospective assessment of the perioperative parameter and treatment outcomes of surgical treatment for benign prostate hyperplasia in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2023.509 | To investigate the effect of multidisciplinary care approach on cardiovascular risk modification in prostate cancer patients receiving androgen deprivation therapy |
Prof. NG Chi Fai Chi Fai NG |
| 2022.051 | A territory-wide retrospective study comparing the effects of different types of androgen deprivation therapy on cardiovascular disease of prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2020.611 | To identify potential new urine marker panel for cancer screening |
Prof. NG Chi Fai 吳志輝 |
| 2022.645 | To linguistically and psychometrically validate the Hong Kong Chinese version of the BPH 3-item questionnaire | Prof. NG Chi Fai |
| 2021.492 | A survey to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2021.684 | A prospective assessment of the perioperative parameter and treatment outcomes of urinary calculi – international registry |
Prof. NG Chi Fai 吳志輝 |
| 2021.484 | Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) |
Prof. NG Chi Fai 吳志輝 |
| 2021.687 | Surgical PRODUCT SURVEILLANCE REGISTRY (PSR) PLATFORM BASE & Medtronic Hugo™ RAS System General Surveillance in Hong Kong Product Surveillance Registry (PSR) Platform Analysis Plan |
Prof. NG Chi Fai 吳志輝 |
| 2023.084 | Clinical Characteristics, Anticholinergic Burden, Treatment Patterns, and Drug Persistence in Patients with Overactive Bladder in Hong Kong: A Real-World Observational Study |
Prof. NG Chi Fai 吳志輝 |
| 2022.394 | Elucidating the functional role of exosomal protein LRG1 and its clinical implication in castration-resistant prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2021.675 | Development of luminescent nanobiosensor for bladder cancer miRNA detection |
Prof. NG Chi Fai 吳志輝 |
| 2023.085 | Association between nephrolithiasis and future cardiovascular events: a population-based analysis of patients utilizing public health systems in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2022.093 | Exploring multiomics biomarkers for urolithiasis |
Prof. NG Chi Fai 吳志輝 |
| 2022.082 | DAROL: Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.301 | A study to evaluate patient and physician benefit/ risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: a discrete choice experiment |
Prof NG Chi Fai 吳志輝 |
| 2021.506 | To investigate the effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy | Prof. NG Chi Fai |
| 2022.158 | The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients |
Prof. NG Chi Fai 吳志輝 |
| 2023.180 | Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long-Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Metastatic Prostate Cancer in Hong Kong. |
Prof. NG Chi Fai 吳志輝 |
| 2020.603 | To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.576 | A retrospective study of the urinary stone composition and its epidemiological and clinical association in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2021.650 | Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study |
Prof. NG Chi Fai 吳志輝 |
| 2022.244 | The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2022.046 | To understand the role of spermine on prostate cancer and its potential therapeutic application |
Prof. NG Chi Fai 吳志輝 |
| 2022.560 | To study the effect of baseline testosterone level on prognosis in Asian patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
| 2018.276 | A prospective randomized study to investigate the effect of extracorporeal shockwave lithotripsy on blood pressure control in patients with hypertension – a pilot study |
Prof. NG Chi Fai 吳志輝 |
| 2019.491 | Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) |
Prof. NG Chi Fai 吳志輝 |
| 2018.280 | A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.166 | A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma |
Prof. NG Chi Fai 吳志輝 |
| 2020.454 | A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of androgen receptor pathway inhibitor (ARPI) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of ARPI |
Prof. NG Chi Fai 吳志輝 |
| 2020.050 | To evaluate the performance of a urine spermine measuring device in predicting prostate biopsy result |
Prof. NG Chi Fai 吳志輝 |
| 2019.534 | To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms |
Prof. NG Chi Fai 吳志輝 |
| 2018.541 | SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.058 | Characterising and Fingerprinting Biomarkers of Urolithiasis: A Case Control Study |
Prof. NG Chi Fai 吳志輝 |
| 2019.662 | The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2019.211 | To establish a reproducible organoid culture model with human kidney cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.323 | Can transperineal prostate biopsy replace transrectal prostate biopsy? Hong Kong experience of the first 100 cases of transperineal prostate biopsy |
Prof. NG Chi Fai 吳志輝 |
| 2019.017 | To investigate the possible underlying causes for patient with nocturia in Hong Kong patients |
Prof. NG Chi Fai 吳志輝 |
| 2018.376 | To identify potential new urine markers for the screening of prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.400 | A retrospective review of the association of baseline characteristics of male patients presented with lower urinary tract and long term clinical outcomes |
Prof. NG Chi Fai 吳志輝 |
| 2020.185 | To compare Spermine Risk Score and Prostate Health Index in diagnosing prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2019.378 | To identify potential new genetic marker for diagnosis of cystinuria. |
Prof. NG Chi Fai 吳志輝 |
| 2018.063 | To investigate the diagnostic accuracy of exosomal microRNA in predicting the aggressiveness of prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2010.474 | Short stay transurethral prostate surgery: A prospective randomized controlled trial comparing efficacy of bipolar transurethral resection/vaporization of prostate with monopolar transurethral resection | Prof Ng Chi Fai |
| 2014.214 | A longitudinal study on the outcome of male voiding dysfunction in Hong Kong Chinese Male | Prof. NG Chi Fai |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2010.494 | A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy | Prof. Ng Chi Fai |
| 2012.105 | ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC | Prof. NG Chi Fai |
| 2009.620 | Strategies To Prevent Renal Trauma | Prof. Ng Chi Fai |
Page 189 of 289.

